SCHEMBL8121522

SCHEMBL8121522

COCOc1ccc(OC)c(F)c1C(=O)c1ccccc1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC25B P30305 3/20 0.49
▸ CLCN2 P51788 1/20 0.46
▸ LMNA P02545 1/20 0.43
▸ HTT P42858 1/20 0.41
▸ MRGPRX4 Q96LA9 1/20 0.41
▸ CYP2C9 P11712 2/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ USP2 O75604 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA7 P43166 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ CA14 Q9ULX7 1/20 0.40
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16333650 0.86 CDC25B (0.48) CDC25BLMNAHTTMRGPRX4CYP2C9
SCHEMBL4630412 0.83 LMNA (0.48) LMNAHTTMRGPRX4CA12CA1
SCHEMBL22394732 0.81 CDC25B (0.54) CDC25BLMNAHTTCYP2C9HIF1A
SCHEMBL4630496 0.76 EGFR (0.45) LMNACYP2C9KMT2ACA12CA1
SCHEMBL2475768 0.75 FABP4 (0.41) CLCN2LMNAHTTMRGPRX4HIF1A
SCHEMBL7482250 0.74 MAPT (0.51) CDC25BLMNAHTTMRGPRX4CA12
SCHEMBL2290756 0.74 ALDH1A1 (0.61) CLCN2LMNAHTTCYP2C9KMT2A
SCHEMBL8132840 0.72 EGFR (0.46) LMNAHTTMRGPRX4CA12CA1
SCHEMBL14855948 0.72 CA12 (0.61) CDC25BLMNAHTTMRGPRX4KMT2A
SCHEMBL27468717 0.72 CLCN2 (0.44) CDC25BCLCN2MRGPRX4CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0663393-B1 3-Amino/hydroxy-4- 4-benzoylphenylcarboxylamino/oxy -azepanes and their homologies as protein kinase inhibitors HOFFMANN LA ROCHE (CH) 2000-07-05 — — EP disclosed
US-5914406-A ENZYME INHIBITOR; USEFUL FOR TREATMENT OF INFLAMMATORY SKIN DISORDERS AND ALOPECIA HOFFMAN-LA ROCHE INC. (US) 1999-06-22 — — US disclosed
US-5750706-A TREATMENT OF INFLAMMATORY SKIN DISORDERS AND ALOPECIA HOFFMANN-LA ROCHE INC. (US) 1998-05-12 — — US disclosed
US-5583222-A ANTIINFLAMMATORY AGENTS FOR TREATMENT OF SKIN DISORDERS HOFFMANN-LA ROCHE INC. (US) 1996-12-10 — — US disclosed
EP-0663393-A1 Novel 3-amino/hydroxy-4- 4-benzoylphenylcarboxylamino/oxy -azepanes and their homologies as protein kinase inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1995-07-19 — — EP disclosed
Send feedback